<DOC>
	<DOCNO>NCT02392039</DOCNO>
	<brief_summary>The goal clinical research study learn loratadine control bone pain cause pegfilgrastim ( drug give chemotherapy help raise white blood cell count ) .</brief_summary>
	<brief_title>Study Loratadine Pegfilgrastim Induced Bone Pain Patients With Aggressive Lymphoma</brief_title>
	<detailed_description>Study Groups : If find eligible take part study , randomly assign ( flip coin ) 1 2 group . You equal chance either group . - If Group 1 , Cycles 1 3 receive loratadine . During Cycles 2 4 , receive placebo . - If Group 2 , Cycles 1 3 receive placebo . During Cycles 2 4 , receive loratadine . A placebo drug . It look like study drug design treat disease illness . It design compare study drug learn study drug real effect . Both group receive pegfilgrastim standard care chemotherapy . Neither study staff know receive study drug placebo . However , need safety , study staff able find receiving . Study Drug Administration : Each study cycle 21 day . On Day 1 Cycles 1-6 , receive pegfilgrastim needle skin . On Days 1-7 Cycles 1-4 , take loratadine/placebo mouth 1 time every day . If bone pain Cycles 1-4 , take loratadine Days 1-7 Cycles 5 6 . If bone pain , study Cycle 4 . The study doctor decide need extra pain medication . You give diary write take loratadine/placebo , write amount time pain medication need , describe location , severity , description pain experience . Study Visits : During Cycles 1-4 ( pain , Cycles 6-7 ) , receive pegfilgrastim Day 7 , complete 3 questionnaire bone pain feel . The take 20 minute complete . If coming clinic , ask mail questionnaire diary . Before cycle start , blood ( 2-4 teaspoon ) draw routine test test liver , bone , kidney . On Day 1 Cycles 2-6 , physical exam , blood ( 3-4 teaspoon ) draw routine test . On Days 7 14 cycle ( +/- 3 day ) , blood ( 2-4 teaspoon ) draw routine test . Length Study : You may continue take study drug 18 week ( 6 cycle ) . You longer able take study drug disease get bad , intolerable side effect occur , unable follow study direction . Your participation study end-of-study visit . End-of-Study Visit : Within 8 week last dose study drug : - You physical exam . - You complete 3 questionnaire bone pain feel . - Blood ( 2-4 teaspoon ) draw routine test test liver , bone , kidney . This investigational study . Loratadine FDA approve commercially available treatment seasonal allergy . Pegfilgrastim FDA approve commercially available improvement chemotherapy-related neutropenia . The use loratadine control bone pain investigational . Up 56 participant enrol study . All take part MD Anderson .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Aggression</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<criteria>1 . Patients must newly diagnose , previously untreated Diffuse Large Bcell Lymphoma , Mantle Cell Lymphoma , Grade 3B Follicular lymphoma , Burkitt Lymphoma , Peripheral T cell Lymphoma NOS , NK/T cell Lymphoma , Transformed lymphoma . 2 . Planned receive chemotherapy 6 cycle treat physician plan utilize pegfilgrastim minimize risk neutropenic fever , include limited RCHOP , REPOCH , RHyperCVAD , CHOP , SMILE . 3 . Age &gt; = 18 year old . 4 . ECOG performance status 03 . 5 . Ability provide inform consent participation . 1 . Existing chronic bone pain prior pegfilgrastim usage . 2 . Creatinine clearance &lt; 50ml/minute Cockcroft Gault equation . 3 . Allergy filgrastim , pegfilgrastim , Loratadine . 4 . Chronic daily usage antihistamine without acceptable alternative nonantihistamine medication . 5 . Inability swallow medication . 6 . Inability complete survey instrumentation accurately .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Lymphoma</keyword>
	<keyword>Diffuse Large B-cell Lymphoma</keyword>
	<keyword>Mantle Cell Lymphoma</keyword>
	<keyword>Grade 3B Follicular Lymphoma</keyword>
	<keyword>Burkitt Lymphoma</keyword>
	<keyword>Peripheral T cell Lymphoma NOS</keyword>
	<keyword>NK/T cell Lymphoma</keyword>
	<keyword>Transformed Lymphoma</keyword>
	<keyword>Aggressive lymphoma</keyword>
	<keyword>Bone pain</keyword>
	<keyword>Pegfilgrastim</keyword>
	<keyword>Neulasta</keyword>
	<keyword>PEG-G-CSF</keyword>
	<keyword>Loratadine</keyword>
	<keyword>Placebo</keyword>
	<keyword>Sugar pill</keyword>
	<keyword>Questionnaires</keyword>
	<keyword>Surveys</keyword>
</DOC>